从TRIDENT-1研究看ROS1融合阳性局部晚期或转移性非小细胞肺癌一线治疗进展

    Progress in First-Line Treatment of ROS1 Fusion-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer From TRIDENT-1 Study

    /

    返回文章
    返回